Fairmount Funds Management LLC Diversified Active

CIK: 0001802528 · Show all filings

Period: Q1 2025 (← Previous) (Next →)

Filing Date: May 15, 2025

Total Value ($000): $644,621 (100.0% shares, 0.0% debt)

Holdings (15)

AXSM AXSOME THERAPEUTICS INC 14.7%

Value ($000) $95,074 Shares 815,176 Est. Cost $49.79 Unrealized +128.8%

APGE APOGEE THERAPEUTICS INC 11.9%

Value ($000) $76,537 Shares 2,048,647 Est. Cost $22.03 Unrealized +75.5%

SYRE SPYRE THERAPEUTICS INC 10.1%

Value ($000) $64,832 Shares 4,018,101 Est. Cost $31.80 Unrealized -34.6%

ELVN ENLIVEN THERAPEUTICS INC 9.8%

Value ($000) $63,031 Shares 3,202,798 Est. Cost $18.66 Unrealized +15.3%

NUVL NUVALENT INC 8.0%

Value ($000) $51,599 Shares 727,563 Est. Cost $22.67 Unrealized +245.0%

DNTH DIANTHUS THERAPEUTICS INC 7.6%

Value ($000) $48,991 Shares 2,700,691 Est. Cost $15.37 Unrealized +43.4%

VRDN VIRIDIAN THERAPEUTICS INC 7.2%

Value ($000) $46,450 Shares 3,445,813 Est. Cost $16.55 Unrealized +2.9%

SRRK SCHOLAR ROCK HLDG CORP 6.9%

Value ($000) $44,175 Shares 1,374,031 Est. Cost $32.56 Unrealized +18.1%

COGT COGENT BIOSCIENCES INC 5.8%

Value ($000) $37,292 Shares 6,225,641 Est. Cost $8.53 Unrealized -8.1%

ORKA ORUKA THERAPEUTICS INC 5.4%

Value ($000) $34,596 Shares 3,371,922 Est. Cost $34.30 Unrealized -63.6%

KNSA KINIKSA PHARMACEUTICALS INTL 3.8%

Value ($000) $24,481 Shares 1,102,248 Est. Cost $18.73 Unrealized +9.9%

— ASTRIA THERAPEUTICS INC 2.9%

Value ($000) $18,979 Shares 3,554,129 Est. Cost $9.99 Unrealized —

ZBIO ZENAS BIOPHARMA INC 2.3%

Value ($000) $14,953 Shares 1,892,806 Est. Cost $17.98 Unrealized -56.5%

IKT INHIBIKASE THERAPEUTICS INC 2.1%

Value ($000) $13,414 Shares 6,125,000 Est. Cost $2.49 Unrealized +0.7%

BCAX BICARA THERAPEUTICS INC 1.6%

Value ($000) $10,218 Shares 784,170 Est. Cost $25.50 Unrealized -47.9%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
AXSM	AXSOME THERAPEUTICS INC	815,176	$95,074	14.7%	$49.79	+128.8%	COM	05464T104
APGE	APOGEE THERAPEUTICS INC	2,048,647	$76,537	11.9%	$22.03	+75.5%	COM	03770N101
SYRE	SPYRE THERAPEUTICS INC	4,018,101	$64,832	10.1%	$31.80	-34.6%	COM NEW	00773J202
ELVN	ENLIVEN THERAPEUTICS INC	3,202,798	$63,031	9.8%	$18.66	+15.3%	COM	29337E102
NUVL	NUVALENT INC	727,563	$51,599	8.0%	$22.67	+245.0%	COM	670703107
DNTH	DIANTHUS THERAPEUTICS INC	2,700,691	$48,991	7.6%	$15.37	+43.4%	COM	252828108
VRDN	VIRIDIAN THERAPEUTICS INC	3,445,813	$46,450	7.2%	$16.55	+2.9%	COM	92790C104
SRRK	SCHOLAR ROCK HLDG CORP	1,374,031	$44,175	6.9%	$32.56	+18.1%	COM	80706P103
COGT	COGENT BIOSCIENCES INC	6,225,641	$37,292	5.8%	$8.53	-8.1%	COM	19240Q201
ORKA	ORUKA THERAPEUTICS INC	3,371,922	$34,596	5.4%	$34.30	-63.6%	COM	687604108
KNSA	KINIKSA PHARMACEUTICALS INTL	1,102,248	$24,481	3.8%	$18.73	+9.9%	ORD SHS CL A	G52694109
—	ASTRIA THERAPEUTICS INC	3,554,129	$18,979	2.9%	$9.99	—	COM	04635X102
ZBIO	ZENAS BIOPHARMA INC	1,892,806	$14,953	2.3%	$17.98	-56.5%	COM	98937L105
IKT	INHIBIKASE THERAPEUTICS INC	6,125,000	$13,414	2.1%	$2.49	+0.7%	COM NEW	45719W205
BCAX	BICARA THERAPEUTICS INC	784,170	$10,218	1.6%	$25.50	-47.9%	COM	055477103